HIGH IMPACT PUBLICATIONS

Aortic Diseases

ACE Trial
(Peterson 2022)

x

Sex differences in Aortic Surgery
(Chung 2019)

x

Surveillance after TAAD
(An 2021)

Bioinformatics

Myocardial Fibrosis Proteomics
(Vanderlaan 2020)

x

x

Clinical Trials

DAPA-HF Trial
(Verma 2019)

EMPEROR REDUCED TRIAL
(Verma 2020)

x

DELIVER TRIAL
(Verma 2022)

RADIAL Trial
(Fremes 2018)

x

DONATE HCV Trial
(Singh 2019)

TRICS Trial
(Verma 2018)

Congenital Heart Disease

HLHS Review
(Barron 2009)

x

Hybrid vs Norwood 
(Honjo 2012)

x

Coronary Revascularization

ART Trial Sub-study
(Fremes 2021)

x

CABG vs PCI for left main disease
(Tam 2023)

x

CABG vs PCI in diabetics
(Tam 2020)

Stem Cells

Mesenchymal Precursor Cells Trial
(Yau 2019)

x

Stem cell-derived endocardium
(Mazine 2021)

x

Valve Disease

Aortic root enlargement study 
(Rocha 2018)

Mitral valve repair review
(Verma 2009)

x

Valve-sparing vs Bentall
(Ouzounian 2016)

Ross vs Mechanical AVR
(Mazine 2016)

x

Long-term results of mitral repair
(David 2019)

TAVR durability simulation study
(Tam 2020)

Contact Us

  • Chair: Dr. Terrence Yau
  • Divisional Program Administraton: Julie Wei

Toronto General Hospital
200 Elizabeth St., 4NU-432
Toronto, On M5G 2C4
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Designed by: Nufuzion Design

Temerty Faculty of Medicine, University of Toronto © 2020